Joint Clinical Practice Guideline on Benzodiazepine Tapering

Zusammenfassung

# Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits ## Abstract Description: The American Society of Addiction Medicine (ASAM) has partnered with nine other medical societies and professional associations representing a wide range of clinical settings and patient populations to provide guidance on evidence-based strategies for tapering benzodiazepine (BZD) medication across a variety of settings. Methods: The guideline was developed foll

Kerninformationen

appropriate for a given patient and, if so, how to taper them. This Guideline applies to adult patients who have been taking BZDs regularly and may be at risk of physical dependence. Note that physical dependence is an expected outcome associated with BZD use and is distinct from BZD use disorder. A...

tients who have been taking BZDs regularly and may be at risk of physical dependence: - Clinicians should base clinical recommendations regarding continued BZD prescribing on ongoing assessment of the risks and benefits of continued BZD use as well as those of tapering/discontinuation (see Table ). ...

n patient response. - Clinicians can consider transitioning patients without contraindications to a comparable dose of a longer-acting BZD medication for the taper (see Appendix ). - Clinicians should monitor patients for the emergence of BZD withdrawal signs and symptoms with each dose reduction. ...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen